Skip to main content

Table 4 Results of screening by Five Year Age Strata: Safety Check and Intervention arms

From: A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

  Safety Check Arm Intervention Arm
Age Strata hr-HPV Negative (%) hr-HPV Positive (%) hr-HPV Unsatis (%) Total hr-HPV Negative (%) hr-HPV Positive (%) hr-HPV Unsatis (%) Total
25-29 117 (76.5) 36 (23.5) 0 (0.0) 153 95 (74.8) 31 (24.4) 1 (0.8) 127
30-34 151 (87.8) 21 (12.2) 0 (0.0) 172 146 (88.0) 20 (12.0) 0 (0.0) 166
35-39 284 (90.2) 31 (9.8) 0 (0.0) 315 239 (88.8) 30 (11.2) 0 (0.0) 269
40-44 324 (92.3) 26 (7.4) 1 (0.3) 351 300 (94.0) 18 (5.6) 1 (0.3) 319
45-49 358 (96.5) 13 (3.5) 0 (0.0) 371 354 (94.1) 19 (5.1) 3 (0.8) 376
50-54 293 (93.9) 18 (5.8) 1 (0.3) 312 267 (94.3) 15 (5.3) 1 (0.4) 283
55-59 232 (96.3) 9 (3.7) 0 (0.0) 241 265 (95.0) 13 (4.7) 1 (0.4) 279
60+ 195 (95.6) 9 (4.4) 0 (0.0) 204 188 (97.4) 4 (2.1) 1 (0.5) 193
Total 1954 (92.2) 163 (7.7) 2 (0.1) 2119 1854 (92.1) 150 (7.5) 8 (0.4) 2012
  1. HPV Digene Negative: Non-reactive for HPV High or Intermediate risk types.
  2. HPV Digene Positive: Reactive for HPV High or Intermediate risk types.
  3. HPV Digene Unsatis: Results unsatisfactory - need to repeat specimen